Skip to content
Screener

Perrigo Company PRGO Specialty Care — Restructuring charges and other termination benefits

Other segment segments

Infant Formula
$14.8M
Self Care
$800K

Similar metrics at other companies

Amneal Pharmaceuticals, Inc. logo
AMRXSpecialty — Restructuring and other charges
$0-100%
EnerSys logo
ENSSpecialty — Restructuring and other exit charges
$863K-40.1%
Henry Schein logo
HSICGlobal Specialty Products — Restructuring Charges
$5M0.0%
Dow logo
DOWPackaging & Specialty Plastics — Restructuring Charges
$2M-98.7%
Knowles logo
KNMedTech & Specialty Audio — Restructuring Charges
$0
Olin logo
OLNOther — Restructuring Charges
$775K0.0%

Other financials

Income statement

See full
Revenue$1.0B-3.2%
Gross profit$313.9M-13.5%
Operating income$23.5M-48.2%
Net income$74.5M+987%
EPS (diluted)$0.53+983%

Balance sheet

See full
Cash & equivalents$399.7M-12.0%
Total debt$3.5B-10.3%
Total equity$2.5B-43.7%
Total assets$7.6B-24.6%

Cash flow

See full
Operating cash flow-$113.6M-76.1%
CapEx$14.3M-25.5%
Free cash flow-$127.4M-41.6%

Valuation

See full
Market cap$1.74B-41.2%
Enterprise value$4.82B-24.7%
P/S0.4×-0.3×

Profitability

See full
Gross margin33.3%-2.5pp
Operating margin-37.7%-44.3pp
Net margin-41.9%-43.9pp
FCF margin4.2%-2.0pp

Returns & leverage

See full
Return on equity-49.6%-51.6pp
Debt / equity1.4×+0.5×
Current ratio2.3×0.0×

Where this comes from

Reported directly by Perrigo Company in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The source filing: Perrigo Company’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 1:44 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001585364-26-000145

Of the amount recorded during three months ended June 27, 2026, our Self Care and Specialty Care segments reversed charges in the amounts of $0.8 million and $3.8 million, respectively, due primarily to adjustments to employee separation costs related to the Operational Enhancement Program. Of the amount recorded during the six months ended June 27, 2026, our Self Care and Specialty Care segments incurred charges in the amounts of $35.8 million and $8.4 million, respectively, due primarily to employee separation costs related to the Operational Enhancement Program. Of the amount recorded during the three and six months ended June 27, 2026, $14.8 million and $22.5 million, respectively, related to our Infant Formula segment, due primarily to Nutrition Network Optimization. Charges totaling $5.0 million and $18.5 million during the three and six months ended June 27, 2026, respectively, primarily for separation costs associated with the Operational Enhancement Program were corporate costs not allocated to a reporting segment.

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Perrigo Company's specialty care — restructuring charges and other termination benefits?
Perrigo Company (PRGO) reported specialty care — restructuring charges and other termination benefits of $3.8M in Q2 2026.
What does specialty care — restructuring charges and other termination benefits mean?
Includes costs associated with reorganizing the Specialty Care segment's operations, such as severance, facility closures, or strategic realignment initiatives. These expenses are typically non-recurring and reflect management's efforts to optimize the segment's cost structure or adapt to changing market conditions. High levels of these charges may indicate significant operational transformation or distress.

Ask your AI about Perrigo Company's specialty care — restructuring charges and other termination benefits.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude